Study finds brain circuit controlling drug withdrawal-induced anxiety and reinstatement

Reviewed by Emily Henderson, B.Sc.May 4 2022

New research from the University of California, Irvine, finds that drug withdrawal-induced anxiety and reinstatement of drug seeking behaviors are controlled by a single pathway in the brain and centered around dopamine cells.

The study, "An extended amygdala-midbrain circuit controlling cocaine withdrawal-induced anxiety and reinstatement," was published today in Cell Reports.

Addiction occurs in phases: initial drug exposures are rewarding, repeated administration leads to tolerance or sensitization to the drug's effects, and withdrawal leads to anxiety and a negative affective state, which, in turn, contribute to reinstatement of drug taking/seeking.

In order to prevent relapse among drug users, specifically cocaine users, we need to understand the factors in the brain that contribute to drug seeking behaviors and the vulnerability to relapse. In this study, we identified a brain circuit that is responsible for drug withdrawal-induced anxiety as well as relapse-related behavior, along with the identification of a potential target for therapeutic interventions."

Kevin Beier, PhD, Assistant Professor, Physiology and Biophysics, School of Medicine, University of California Irvine

The negative affective state induced by withdrawal from use of drugs of abuse is a critical factor causing drug users to relapse.

"Both the drug withdrawal-induced anxiety and reinstatement of drug seeking are controlled by a single pathway centered around dopamine cells in the ventral midbrain," explained Beier. "That a single pathway controls both sets of behavioral changes may help to explain many addiction-related behavioral phenomena. Importantly, it links them both directly to dopamine, which is more typically linked to reward-related behaviors."

Although midbrain dopamine circuits are central to motivated behaviors, the knowledge of how experience modifies these circuits to facilitate subsequent behavioral adaptations is limited. This study demonstrates the selective role of a ventral tegmental area dopamine projection to the amygdala for cocaine induced anxiety, but not cocaine reward or sensitization. Silencing this projection prevents development of anxiety during protracted withdrawal after cocaine use.

According to the National Center for Drug Abuse Statistics, there are roughly 70,000 drug overdoses each year in the United States. In 2017, nearly one in five drug overdose deaths was cocaine-related, with the highest rate of cocaine-related overdoses and deaths occurring among non-Hispanic black populations. Between 2012 and 2018, the rate of cocaine-related overdose deaths increased from 1.4 to 4.5 percent. The American Addiction Centers state recent drug relapse statistics show that more than 85 percent of individuals relapse and return to drug use within a year following treatment.

This work was supported by the National Institutes of Health, Tobacco-Related Disease Research Program, American Parkinson Disease Association, Alzheimer's Association, New Vision Research, and the Brain and Behavior Research Foundation.